Skip to main content

Table 1 Characteristics and classification of study population

From: Delayed post-diuretic 18F-FDG PET/CT: can it help in determination of the best clinical decision for muscle invasive UB cancer patients?

Age groups30–39 years5 [14.2%]
40–49 years11 [31.4%]
50–59 years16 [45.7%]
> 59 years3 [8.5%]
SexMale32 [91.4%]
Female3 [8.5%]
PathologyTransitional cell ca.31 [88.5%]
Squamous cell ca.4 [11.4%]
GroupsGroup A: initial staging18 [51.4%]
 Group B: post-therapeutic evaluation17 (48.6%)